Liver bioactivation

Liver bioactivation hepatotrophic factors complement proteins... 

All of the following statements r atding liver bioactivation of xenobiotics to a more toxic fbtm are true exc f ... 

Phytochemicals have little nutritional value and do not get absorbed in the body, but they seem to turn on certain switches in the biochemical mechanisms, which signal the beneficial pathways to maintain health, and to turn off the switches which proceed to adverse biochemical pathways. Rice bran products have demonstrated significant benefits as nutritional therapies in diabetes, hyperlipidemia, cancer, fatty liver, hypercalcuria and heart disease. There is experimental and clinical evidence for the beneficial health effects of the following bioactives of rice bran ... 

A knowledge of physiology and pharmacokinetics is needed (Fanis et al. 1993 Monteiro and Furness 2001). Levels of mercuiy normally vary among internal tissues, and the time to equilibrate within each tissue varies. For example, blood mercury levels normally reflect veiy recent exposure, while brain and liver levels reflect longer-term exposure. Tissue-specific mechanisms of detoxification and seqnestration, among other processes, must be understood to define the bioactive moiety in observed tissue bmdens before a clear expression of toxicity can be derived (Woodetal. 1997). 

Iverson, S. L. Shen, L. Anlar, N. Bolton, J. L. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem. Res. Toxicol. 1996, 9, 492-A99. 

Researchers focused on the metabolically competent human hepatoma cell line HepG2 as a model of human liver. HepG2 cells are a well-known hepatoma cell line that retains many of the morphological characteristics of liver parenchymal cells. This model is often used as a useful tool for HRA/ERA-oriented chemical risk assessment due to the expression of antioxidant and xenobiotic metabolizing enzymes (in particular phase I and phase II enzymes responsible for the bioactivation/detoxification of various xenobiotics) that can be induced or inhibited by dietary and non-dietary agents [28-30]. 

KNOB protein, however, was shown to improve gene expression markedly (130-fold in HeLa cells). Additionally, it was shown that PEG could be conjugated to the surface of the nanospheres to prevent aggregation during lyophilization without a loss of bioactivity following one month in storage. The PEGylated particles, however, were cleared from mice at a slower rate than unmodified controls and were found to accumulate in the kidney and liver at 15 min after intravenous administration. There was no difference after one hour, however. 

The same urethane linker group that is a feature of conjugates 138 and 139 (Section 5.03.12) has also been used to provide SIN-1 13 conjugates of two vitamin E analogues, 6-tochopherol and Torolox , that undergo enzymatic bioactivation in the presence of porcine liver esterase to release nitric oxide <2006MI363>. 

The metabolism of 77-hexane takes place in the liver. The initial reaction is oxidation by cytochrome P-450 isozymes to hexanols, predominantly 2-hexanol. Further reactions convert 2-hexanol to 2-hexanone, 2,5-hexanediol, 5-hydroxy-2-hexanone, 4,5-dihydroxy-2-hexanone and the neurotoxicant 2,5-hexanedione. Hydroxylation at the 1- and 3- positions can be considered detoxification pathways hydroxylation at the 2- position is a bioactivation pathway. A diagram of the proposed pathway for mammalian metabolism of -hexane is presented in Figure 2-3. 

First generation of topi inhibitors were developed as drugs from camptothecins, a family of compounds derived from wood and bark of the Chinese tree Camptotheca acuminata) [9, 10], Many of these are already in clinical use or clinical trials, including irinotecan, topotecan, exatecan, rubitecan, and lurtotecan. Irinotecan (CPT-11) is bioactivated in liver by carboxylesterase to the active metabolite SN-38, 1000-fold more active [11]. Irinotecan received in 1998 FDA approval for treatment of metastatic colorectal cancer after failure of treatment with 5FU [12],... 

C. A. Mugford, J. B. Tarloff, The Contribution of Oxidation and Deacetylation to the Bioactivation of Acetaminophen in vitro in Liver and Kidney from Male and Female Spargue-Dawley Rats , Drug Metab. Dispos. 1995, 23, 290-294. 

In contrast to the A-monosubstituted carbamates, the A,A-disubstituted analogues (8.124 and 8.125, R = R R"NCO R = Me or Et R" = Me, Et, i-Pr, etc.) proved very stable at pH 7.4 in both buffer and plasma, with less than 5% degradation in 4 d. In fact, these compounds were potent inhibitors of plasma cholinesterase (EC 3.1.1.8), with K values ranging from 600 to 3 nM. Although these carbamates were stable in plasma, they underwent rapid bioactivation in liver, as demonstrated with mouse and rat liver microsomes. For example, the A,A-dimethylcarbamate (8.124, R = Me2NCO) was bioactivated in rat liver microsomes with t1/2 of ca. 30 min. Two routes of bioactivation were postulated, namely direct carboxylesterase-catalyzed hydrolysis, and cytochrome P450 mediated A-dealkylation to a more labile A-monosubstituted carbamate. 

Dayer P, Desmeules J, Leemann T, Stribemi R. 1988. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/ bufl). Biochem Biophys Res Commun 152 411-416. 

No studies were located indicating that any populations are unusually susceptible to heptachlor or heptachlor epoxide. There is a possibility that very young children may exhibit particular susceptibility to hepatic effects because of the immaturity of the hepatic microsomal system. Heptachlor is bioactivated to produce heptachlor epoxide which is more toxic than heptachlor. Preadolescent children have a greater rate of glutathione turnover, and they are expected to be more susceptible to heptachlor epoxide-induced toxicity. Their susceptibility would probably depend upon their ability to detoxify heptachlor epoxide. Individuals who show reduced liver function for other... 

Because these different viability tests all reflect different aspects of cell viability, the choice of test depends on the aim of the study. For toxicity studies where biotransformation is an important bioactivation or detoxification step, metabolic function tests should be included to judge the validity of the method, whereas viability tests are needed to assess toxic effects. Both positive and negative controls should be included in such studies. When human liver is used, the characterization of metabolic activity is especially important because of the large inter-individual variability associated with this property [75]. 

Data is expressed as picomolar equivalents per milligram of protein and is equivalent since the exact nature of the species bound at this point is unknown. Typically both human and rat liver microsomes would be used in order to get an estimate of bioactivation, since there may be substantial species differences. The rat data may be correlated with rat in vivo data to help contextualize the human data. 

---